ArticleBMC cancer2018

GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer.

Dan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.